Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.610
+0.010 (0.38%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 19.76 | 23.63 | 17.11 | 38.99 | 18.27 | Upgrade
|
| Short-Term Investments | 15.07 | 20.93 | 5.07 | - | 20.28 | Upgrade
|
| Cash & Short-Term Investments | 34.83 | 44.56 | 22.18 | 38.99 | 38.55 | Upgrade
|
| Cash Growth | -21.84% | 100.90% | -43.11% | 1.14% | 116.64% | Upgrade
|
| Accounts Receivable | 2.91 | 5.27 | 4.59 | 3.44 | 2 | Upgrade
|
| Other Receivables | 0.49 | 0.48 | 0.36 | 0.31 | 0.77 | Upgrade
|
| Receivables | 3.4 | 5.75 | 4.95 | 3.75 | 2.77 | Upgrade
|
| Inventory | 21.24 | 19.05 | 16.8 | 17.95 | 13.08 | Upgrade
|
| Prepaid Expenses | 0.5 | 0.44 | 0.77 | 0.91 | 0.84 | Upgrade
|
| Other Current Assets | 0.11 | 0.13 | 0.17 | 0.07 | 0.48 | Upgrade
|
| Total Current Assets | 60.08 | 69.93 | 44.88 | 61.67 | 55.72 | Upgrade
|
| Property, Plant & Equipment | 10.02 | 10.88 | 9.64 | 9.92 | 10.41 | Upgrade
|
| Long-Term Deferred Tax Assets | 2.86 | 3.09 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.46 | 0.53 | 1.27 | 2.08 | 1.8 | Upgrade
|
| Total Assets | 73.42 | 84.43 | 55.79 | 73.67 | 67.93 | Upgrade
|
| Accounts Payable | 4.53 | 4.32 | 5.86 | 6.99 | 7.22 | Upgrade
|
| Accrued Expenses | 13.8 | 13.2 | 11.6 | 16.34 | 13.61 | Upgrade
|
| Current Portion of Long-Term Debt | - | 20.25 | - | - | 58.51 | Upgrade
|
| Current Portion of Leases | 1.5 | 1.41 | 1.12 | 1.21 | 1.42 | Upgrade
|
| Current Income Taxes Payable | 3.48 | 2.88 | 0.53 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 13.18 | 8.55 | 5.39 | Upgrade
|
| Other Current Liabilities | 2.31 | 3.48 | 0.14 | 0.1 | 0.32 | Upgrade
|
| Total Current Liabilities | 25.62 | 45.53 | 32.43 | 33.18 | 86.47 | Upgrade
|
| Long-Term Debt | - | - | 28.19 | 27.89 | - | Upgrade
|
| Long-Term Leases | 4.03 | 4.62 | 4.17 | 4.38 | 4.47 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 11.79 | 1.72 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.05 | Upgrade
|
| Total Liabilities | 30.21 | 50.87 | 66.43 | 79.7 | 94.97 | Upgrade
|
| Common Stock | 0.08 | 0.07 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 421.53 | 415.05 | 379.17 | 368.85 | 320.28 | Upgrade
|
| Retained Earnings | -378.39 | -381.55 | -389.86 | -374.93 | -347.35 | Upgrade
|
| Shareholders' Equity | 43.21 | 33.57 | -10.64 | -6.04 | -27.04 | Upgrade
|
| Total Liabilities & Equity | 73.42 | 84.43 | 55.79 | 73.67 | 67.93 | Upgrade
|
| Total Debt | 5.53 | 26.28 | 33.47 | 33.47 | 64.4 | Upgrade
|
| Net Cash (Debt) | 29.3 | 18.28 | -11.29 | 5.52 | -25.86 | Upgrade
|
| Net Cash Growth | 60.31% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.36 | 0.22 | -0.23 | 0.12 | -0.89 | Upgrade
|
| Filing Date Shares Outstanding | 78.03 | 73.05 | 57.35 | 46.32 | 45.38 | Upgrade
|
| Total Common Shares Outstanding | 75.85 | 72.95 | 53.79 | 45.56 | 34.77 | Upgrade
|
| Working Capital | 34.46 | 24.4 | 12.45 | 28.49 | -30.75 | Upgrade
|
| Book Value Per Share | 0.57 | 0.46 | -0.20 | -0.13 | -0.78 | Upgrade
|
| Tangible Book Value | 43.21 | 33.57 | -10.64 | -6.04 | -27.04 | Upgrade
|
| Tangible Book Value Per Share | 0.57 | 0.46 | -0.20 | -0.13 | -0.78 | Upgrade
|
| Machinery | 22.42 | 22.02 | 21.32 | 20.96 | 20.11 | Upgrade
|
| Leasehold Improvements | 17.91 | 17.64 | 16.92 | 16.76 | 16.66 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.